Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 May;87(5):1490–1495. doi: 10.1172/JCI115158

Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant.

F C Arnett 1, M L Olsen 1, K L Anderson 1, J D Reveille 1
PMCID: PMC295227  PMID: 1673688

Abstract

Autoantibodies to phospholipids (APA) occur frequently in systemic lupus erythematosus (SLE) and other autoimmune disorders and predispose to intravascular thromboses. Major histocompatibility complex (MHC) class II alleles (HLA-DR and DQ) were determined by restriction fragment length polymorphisms (RFLP) in 20 patients with APA (lupus anticoagulant). HLA-DQw7 (DQB1*0301), linked to HLA-DR5 and -DR4 haplotypes, occurred in 70% and was significantly increased compared to 139 race-matched normal controls (P = 0.002, P corrected [pc] = 0.05, odds ratio [OR] = 5.1). Moreover, the frequency of HLA-DQw7 was significantly higher in SLE patients with APA as compared with patients without APA but with other autoantibodies, including anti-Ro and La (P = 0.0001, pc = 0.002, OR = 10.7), anti-Ro alone (P = 0.001, pc = 0.02, OR = 11.2), anti-dsDNA (P = 0.001, pc = 0.02, OR = 7.1), and possibly anti-Sm (P = 0.04, pc = NS, OR = 6.8) and anti-nRNP (U1-RNP) (P = 0.01, pc = NS, OR = 7.8). The DQB1*0301 allele of DQw7 showed the strongest association, while the frequencies of the DQA1*0301 (45%) and DQA1*0501 (50%) alleles did not differ from the controls. Among the HLA-DQB1*0301 (DQw7) negative patients, all possessed HLA-DQw8 (DQB1*0302) and/or HLA-DQw6 (DQB1*0602 or DQB1*0603) alleles. The HLA-DQB1*0301 chain shares an identical seven amino acid sequence with DQB1*0302, *0602, and *0603 chains in the third hypervariable region of the HLA-DQ molecule. This candidate "epitope" may play a role in mediating an autoimmune response to APA.

Full text

PDF
1490

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., de Groot E. R., Feltkamp T. E. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci. 1975 Jun 30;254:505–515. doi: 10.1111/j.1749-6632.1975.tb29197.x. [DOI] [PubMed] [Google Scholar]
  2. Ahearn J. M., Provost T. T., Dorsch C. A., Stevens M. B., Bias W. B., Arnett F. C. Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 1982 Sep;25(9):1031–1040. doi: 10.1002/art.1780250901. [DOI] [PubMed] [Google Scholar]
  3. Asherson R. A., Khamashta M. A., Ordi-Ros J., Derksen R. H., Machin S. J., Barquinero J., Outt H. H., Harris E. N., Vilardell-Torres M., Hughes G. R. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989 Nov;68(6):366–374. [PubMed] [Google Scholar]
  4. Bell D. A., Maddison P. J. Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum. 1980 Nov;23(11):1268–1273. doi: 10.1002/art.1780231107. [DOI] [PubMed] [Google Scholar]
  5. Bell J. I., Denney D., Jr, MacMurray A., Foster L., Watling D., McDevitt H. O. Molecular mapping of class II polymorphisms in the human major histocompatibility complex. I. DR beta. J Immunol. 1987 Jul 15;139(2):562–573. [PubMed] [Google Scholar]
  6. Bidwell J. L., Bidwell E. A., Savage D. A., Middleton D., Klouda P. T., Bradley B. A. A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation. 1988 Mar;45(3):640–646. doi: 10.1097/00007890-198803000-00027. [DOI] [PubMed] [Google Scholar]
  7. Blin N., Stafford D. W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 1976 Sep;3(9):2303–2308. doi: 10.1093/nar/3.9.2303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bodmer J. G., Marsh S. G., Parham P., Erlich H. A., Albert E., Bodmer W. F., Dupont B., Mach B., Mayr W. R., Sasazuki T. Nomenclature for factors of the HLA system, 1989. Hum Immunol. 1990 Jul;28(3):326–342. doi: 10.1016/0198-8859(90)90060-3. [DOI] [PubMed] [Google Scholar]
  9. Carlsson B., Wallin J., Böhme J., Möller E. HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology. Hum Immunol. 1987 Oct;20(2):95–113. doi: 10.1016/0198-8859(87)90025-5. [DOI] [PubMed] [Google Scholar]
  10. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  11. Gammon W. R., Heise E. R., Burke W. A., Fine J. D., Woodley D. T., Briggaman R. A. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol. 1988 Sep;91(3):228–232. doi: 10.1111/1523-1747.ep12470317. [DOI] [PubMed] [Google Scholar]
  12. Gibofsky A., Winchester R. J., Patarroyo M., Fotino M., Kunkel H. G. Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J Exp Med. 1978 Dec 1;148(6):1728–1732. doi: 10.1084/jem.148.6.1728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldstein R., Duvic M., Targoff I. N., Reichlin M., McMenemy A. M., Reveille J. D., Warner N. B., Pollack M. S., Arnett F. C. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum. 1990 Aug;33(8):1240–1248. doi: 10.1002/art.1780330826. [DOI] [PubMed] [Google Scholar]
  14. Gregersen P. K. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease. Lab Invest. 1989 Jul;61(1):5–19. [PubMed] [Google Scholar]
  15. Gyllensten U. B., Erlich H. A. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7652–7656. doi: 10.1073/pnas.85.20.7652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hamilton R. G., Harley J. B., Bias W. B., Roebber M., Reichlin M., Hochberg M. C., Arnett F. C. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum. 1988 Apr;31(4):496–505. doi: 10.1002/art.1780310406. [DOI] [PubMed] [Google Scholar]
  17. Harley J. B., Reichlin M., Arnett F. C., Alexander E. L., Bias W. B., Provost T. T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science. 1986 May 30;232(4754):1145–1147. doi: 10.1126/science.3458307. [DOI] [PubMed] [Google Scholar]
  18. Harris E. N., Gharavi A. E., Boey M. L., Patel B. M., Mackworth-Young C. G., Loizou S., Hughes G. R. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983 Nov 26;2(8361):1211–1214. doi: 10.1016/s0140-6736(83)91267-9. [DOI] [PubMed] [Google Scholar]
  19. Hart R. G., Miller V. T., Coull B. M., Bril V. Cerebral infarction associated with lupus anticoagulants--preliminary report. Stroke. 1984 Jan-Feb;15(1):114–118. doi: 10.1161/01.str.15.1.114. [DOI] [PubMed] [Google Scholar]
  20. Johnson G. D., Edmonds J. P., Holborow E. J. Precipitating antibody to D.N.A. detected by two-stage electroimmunodiffusion. Study in S.L.E. and in rheumatoid arthritis. Lancet. 1973 Oct 20;2(7834):883–885. doi: 10.1016/s0140-6736(73)92008-4. [DOI] [PubMed] [Google Scholar]
  21. Kohonen-Corish M. R., Serjeantson S. W. HLA-DR beta gene DNA polymorphisms revealed by Taq I correlate with HLA-DR specificities. Hum Immunol. 1986 Mar;15(3):263–271. doi: 10.1016/0198-8859(86)90002-9. [DOI] [PubMed] [Google Scholar]
  22. Larhammar D., Hyldig-Nielsen J. J., Servenius B., Andersson G., Rask L., Peterson P. A. Exon-intron organization and complete nucleotide sequence of a human major histocompatibility antigen DC beta gene. Proc Natl Acad Sci U S A. 1983 Dec;80(23):7313–7317. doi: 10.1073/pnas.80.23.7313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Long E. O., Wake C. T., Gorski J., Mach B. Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes. EMBO J. 1983;2(3):389–394. doi: 10.1002/j.1460-2075.1983.tb01435.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Love P. E., Santoro S. A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990 May 1;112(9):682–698. doi: 10.7326/0003-4819-112-9-682. [DOI] [PubMed] [Google Scholar]
  25. MacMurray A. J., Bell J. I., Denney D., Jr, Watling D., Foster L. S., McDevitt H. O. Molecular mapping class II polymorphisms in the human major histocompatibility complex. II. DQ beta. J Immunol. 1987 Jul 15;139(2):574–586. [PubMed] [Google Scholar]
  26. McDaniel D. O., Acton R. T., Barger B. O., Koopman W. J., Reveille J. D. Association of a 9.2-kilobase Pvu II class I major histocompatibility complex restriction fragment length polymorphism with ankylosing spondylitis. Arthritis Rheum. 1987 Aug;30(8):894–900. doi: 10.1002/art.1780300808. [DOI] [PubMed] [Google Scholar]
  27. McHugh N. J., Maddison P. J. HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 1989 Dec;32(12):1623–1624. doi: 10.1002/anr.1780321222. [DOI] [PubMed] [Google Scholar]
  28. Reinertsen J. L., Klippel J. H., Johnson A. H., Steinberg A. D., Decker J. L., Mann D. L. B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med. 1978 Sep 7;299(10):515–518. doi: 10.1056/NEJM197809072991004. [DOI] [PubMed] [Google Scholar]
  29. Reveille J. D., Schrohenloher R. E., Acton R. T., Barger B. O. DNA analysis of HLA-DR and DQ genes in American blacks with systemic lupus erythematosus. Arthritis Rheum. 1989 Oct;32(10):1243–1251. doi: 10.1002/anr.1780321009. [DOI] [PubMed] [Google Scholar]
  30. Savi M., Ferraccioli G. F., Neri T. M., Zanelli P., Dall'Aglio P. P., Tincani A., Balestrieri G., Carella G., Cattaneo R. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum. 1988 Dec;31(12):1568–1570. doi: 10.1002/art.1780311216. [DOI] [PubMed] [Google Scholar]
  31. Spielman R. S., Lee J., Bodmer W. F., Bodmer J. G., Trowsdale J. Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3461–3465. doi: 10.1073/pnas.81.11.3461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  33. Todd J. A., Acha-Orbea H., Bell J. I., Chao N., Fronek Z., Jacob C. O., McDermott M., Sinha A. A., Timmerman L., Steinman L. A molecular basis for MHC class II--associated autoimmunity. Science. 1988 May 20;240(4855):1003–1009. doi: 10.1126/science.3368786. [DOI] [PubMed] [Google Scholar]
  34. Trimble M., Bell D. A., Brien W., Hachinski V., O'Keefe B., McLay C., Black J. The antiphospholipid syndrome: prevalence among patients with stroke and transient ischemic attacks. Am J Med. 1990 Jun;88(6):593–597. doi: 10.1016/0002-9343(90)90523-g. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES